Related Experiment Video
Updated: Jan 24, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events
Kei Kunimasa1, Harumi Nakamura2, Kazuko Sakai3
1Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Japan.
Objectives:
SMARCA4-deficient thoracic sarcoma(DTS) is a recently identified new entity of thoracic malignancies characterized by inactivation of SMARCA4. Patients with SMARCA4-DTS have a particulary aggresive clinical course and no effective treatments. However, the detailed clinical features of SMARCA4-DTS remain unclear. Here, we report the clinical courses and molecular profiles of two cases of SMARCA4-DTS.
Materials And Methods:
We experienced strikingly similar two patients of SMARCA4-DTS. The clinicopathologic features were reviewed, and detailed immunohistochemical and comprehensive cancer panel analysis with next generation sequencing confirmed the diagnosis.
Results:
Our cases had many clinical and radiological observations characteristic of SMARCA4-DTS in common. Immunohistochemical staing showed complete loss of SMARCA4 in tumor cells. Loss of function mutations were detected in SMARCA4. We found that severe SREs comprise a new significant clinical feature of SMARCA4-DTS.
Conclusion:
Integrated clinico-radiologic-pathologic-genetic diagnosis is essential for SMARCA4-DTS and physicians should pay attention to severe SREs during the clinical course of this disease.
Insights
SMARCA4-deficient thoracic sarcoma (DTS) is an aggressive cancer. This study highlights severe skeletal-related events as a key clinical feature, emphasizing integrated diagnosis for better patient outcomes.
Area of Science:
- Oncology
- Molecular Pathology
- Genetics
Background:
- SMARCA4-deficient thoracic sarcoma (DTS) is a newly identified thoracic malignancy.
- This cancer is characterized by SMARCA4 gene inactivation and exhibits an aggressive clinical course.
- Effective treatments for SMARCA4-DTS are currently lacking, and detailed clinical features remain unclear.
Observation:
- Two cases of SMARCA4-DTS with similar clinical and radiological presentations were analyzed.
- Immunohistochemical staining revealed a complete loss of SMARCA4 expression in tumor cells.
- Comprehensive cancer panel analysis and next-generation sequencing identified loss-of-function mutations in SMARCA4.
Findings:
- The study identified severe skeletal-related events (SREs) as a significant clinical feature of SMARCA4-DTS.
- Clinical, radiological, and molecular profiles were consistent across both reported cases.
- Loss of SMARCA4 expression and mutations were confirmed through molecular analyses.
Implications:
- Integrated clinico-radiologic-pathologic-genetic diagnosis is crucial for accurate SMARCA4-DTS identification.
- Clinicians should be vigilant for severe SREs during the management of SMARCA4-DTS patients.
- Understanding these features can potentially guide future therapeutic strategies for this rare malignancy.
Related Concept Videos
Thoracic Aorta
The Thoracic Cage: Sternum
The sternum is the elongated bony structure on the anterior side of the thoracic cage. It consists of three parts: the manubrium, the body, and the xiphoid...
The Thoracic Cage: Ribs
Parts of a Typical Rib
A typical rib has a head, neck, and body. The posterior end of the rib is called the head, followed by a narrow neck. The head articulates primarily with the costal...
Classification of Skeletal Muscle Fibers
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
Pressure Relationships in Thoracic Cavity
Breathing Mechanisms
Both intra-alveolar and intrapleural pressures rely on specific lung properties. The ability to breathe—allowing air to enter the lungs...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

